Develops pharmaceuticals through drug delivery system

Gencia, LLC operates as a biotechnology company. The company was founded in 2002 and is based in Charlottesville, Virginia.

TheVax Genetics Vaccine Co., Ltd. engages in the manufacture, research, and development of human vaccines. Its products include PEK fusion proteins such as TVGV-1 designed for the treatment of human papilloma virus (HPV). It also engages in the research of innovative health control solutions and provides biotechnology services. The company was founded by Hsiu Kang Chang on June 27, 2012 and is headquartered in Taipei, Taiwan.

Aliophtha is work on Research and development in the field of pharmaceutical products, including biological and biotechnological products, and manufacturing and commercialization of such products, research in the field of medical technology, and development, manufacture and distribution of medical device and products and related industries.

Taiga Biotechnologies is a clinical-stage company focused on harnessing the immune system to fight infectious disease and cancer. The company's Bone Marrow Engraftment Enhancer (BMEE) program is developing a first-line product, TBX-1400, to enhance the engraftment of hematopoietic stem and progenitor cells during an allogeneic hematopoietic stem cell transplant (HSCT). Taiga Biotechnologies lead Cell-Based Immunotherapy product candidate, TBX-3400, uses a patient’s own immune cells to help fight against cancer and infectious disease. TBX-3400 is an autologous cell product made from peripheral blood mononuclear cells that are treated ex vivo with our fusion protein and then delivered intravenously back to the patient the following day. They developing technologies to generate red blood cells in the laboratory for clinical applications and products to improve the utility of red blood cell products.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

The Board of Trustees of the University of Illinois, part of University of Illinois, is a company headquartered in Urbana, IL, that trusts Except Educational Religious.

Cognosci Inc. was founded in May 2000 to develop anti-inflammatory compounds for the treatment of neuroinflammatory diseases including Multiple Sclerosis, Alzheimer's Disease, and brain bleeding events. Each of these disorders has a pharmacogenomic linkage to the apolipoprotein E (APOE) protein and patients with the APOE-ε4 allele typically suffer worse outcomes. Based on these findings, scientists from Duke University created a novel APOE-based compound that had potent anti-inflammatory and neuroprotective activities.

ToolGen, a biotechnology company, focuses on the development of genome editing technology. Its products include gRNA/Cas9 purified that provides ready-to-use reagents for genome engineering experiments; gRNA/Cas9 plasmid that offers tools for genome editing experiment; and recombinant Cas9 protein that offers ready-to-use reagents for genome engineering experiments. ToolGen also offers genome-edited cell line; genome-edited mouse/rat; and genome-edited plant services, as well as surrogate reporter synthesis and in-del analysis services. Its products are used in research applications. ToolGen began operation in 1999, with its headquarters in Seoul in South Korea. ToolGen is a subsidiary of NSN.

OyaGen, Inc., a biotechnology company, engages in discovering, developing, and commercializing novel pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. Its platform technology encompasses on study of editing enzymes to affect various functions, including antiviral, cancer, immunoglobulin gene rearrangements, inflammation, ion channel function, LDL reduction, neuro-cognitive functions, and red blood cell expression in fetal liver. OyaGen, Inc. was founded in 2003 and is based in Rochester, New York.

BioCeltran, Inc. is a South Korean private company located in Chuncheon that provides research on bio products.

Artemis Pharma, Inc. provides health care services. It develops agents for the prevention and treatment of severe and potentially life-threatening infectious diseases. The company is headquartered in United States. Therapeutics

CDG Therapeutics is a biotechnology company, that provides services, science and technology, significant opportunity for development, pipeline, intellectual property, numerous international patent applications, a spectrum of metastatic, solid tumors and progressive, pediatric central nervous system (CNS) malignancies, peptide drug prototypes and analogs, chemical synthesis.

The Lee Co. supplies precision fluid control products to industries including aerospace, formula 1 racing, oil exploration, automotive and off-highway equipment, and medical and scientific instruments. Its products include precision microhydraulics and electro-fluidic systems. The company was founded by Leighton Lee II in 1948 and is headquartered in Westbrook, CT.

Lonza Walkersville, Inc. develops, manufactures and provides testing services for cell-based therapeutics. Its services include life-science customers, research organizations, pharmaceutical, biopharmaceutical, biotechnology and generic drug companies. The company was founded was founded on May 9, 1991 and is headquartered in Walkersville, MD.